Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023
Kiniksa Pharmaceuticals to report Q3 2023 financial results and recent portfolio execution
Positive
Kiniksa Pharmaceuticals will host a conference call and webcast to report its third quarter 2023 financial results and recent portfolio execution. The live webcast will be accessible through the company's website. A replay of the event will also be available on the website.
10/24/2023 - 04:01 PM
HAMILTON, Bermuda, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, October 31, 2023 at 8:30 a.m. Eastern Time to report its third quarter 2023 financial results and recent portfolio execution.
A live webcast will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com . Individuals interested in participating in the call via telephone may register here . Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.
About Kiniksa Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s immune-modulating assets, ARCALYST, KPL-404, and mavrilimumab, are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visit www.kiniksa.com .
ARCALYST® is a registered trademark of Regeneron Pharmaceuticals, Inc.
Every Second Counts! ®
Kiniksa Investor and Media Contact Rachel Frank (339) 970-9437r frank@kiniksa.com
When will Kiniksa Pharmaceuticals report its Q3 2023 financial results?
Kiniksa Pharmaceuticals will report its Q3 2023 financial results on Tuesday, October 31, 2023.
How can I access the conference call and webcast?
The conference call and webcast can be accessed through the Investors & Media section of Kiniksa Pharmaceuticals' website.
Will there be a replay of the event?
Yes, a replay of the event will be available on Kiniksa Pharmaceuticals' website within approximately 48 hours after the event.
Kiniksa Pharmaceuticals Ltd
KNSA Rankings
#604 Ranked by Stock Gains
KNSA Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Major, Manufacturing, Pharmaceutical Preparation Manufacturing
About KNSA
kiniksa pharmaceuticals combines an experienced management team and significant committed capital in order to acquire, develop, and commercialize therapeutics treating devastating diseases with high unmet needs.